586 related articles for article (PubMed ID: 32360643)
1. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
[TBL] [Abstract][Full Text] [Related]
2. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
[TBL] [Abstract][Full Text] [Related]
3. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
J Toxicol Environ Health A; 2020 Jul; 83(13-14):485-494. PubMed ID: 32552445
[TBL] [Abstract][Full Text] [Related]
4. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Hengstler J; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Food Chem Toxicol; 2020 Aug; 142():111349. PubMed ID: 32360905
[TBL] [Abstract][Full Text] [Related]
5. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Chem Biol Interact; 2020 Aug; 326():109099. PubMed ID: 32370863
[TBL] [Abstract][Full Text] [Related]
6. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Arch Toxicol; 2020 Jul; 94(7):2549-2557. PubMed ID: 32514609
[TBL] [Abstract][Full Text] [Related]
7. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Toxicol Lett; 2020 Oct; 331():259-264. PubMed ID: 32360654
[No Abstract] [Full Text] [Related]
8. Editorial on editorial: Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Toxicol In Vitro; 2020 Sep; 67():104862. PubMed ID: 32360642
[No Abstract] [Full Text] [Related]
9. Methodological issues in human studies of endocrine disrupting chemicals.
Lee DH; Jacobs DR
Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
[TBL] [Abstract][Full Text] [Related]
10. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals.
Vandenberg LN; Ågerstrand M; Beronius A; Beausoleil C; Bergman Å; Bero LA; Bornehag CG; Boyer CS; Cooper GS; Cotgreave I; Gee D; Grandjean P; Guyton KZ; Hass U; Heindel JJ; Jobling S; Kidd KA; Kortenkamp A; Macleod MR; Martin OV; Norinder U; Scheringer M; Thayer KA; Toppari J; Whaley P; Woodruff TJ; Rudén C
Environ Health; 2016 Jul; 15(1):74. PubMed ID: 27412149
[TBL] [Abstract][Full Text] [Related]
11. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies.
Wan MLY; Co VA; El-Nezami H
Crit Rev Food Sci Nutr; 2022; 62(24):6549-6576. PubMed ID: 33819127
[TBL] [Abstract][Full Text] [Related]
12. Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.
Hotchkiss AK; Rider CV; Blystone CR; Wilson VS; Hartig PC; Ankley GT; Foster PM; Gray CL; Gray LE
Toxicol Sci; 2008 Oct; 105(2):235-59. PubMed ID: 18281716
[TBL] [Abstract][Full Text] [Related]
13. Possible relationship between endocrine disrupting chemicals and hormone dependent gynecologic cancers.
Dogan S; Simsek T
Med Hypotheses; 2016 Jul; 92():84-7. PubMed ID: 27241264
[TBL] [Abstract][Full Text] [Related]
14. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.
Yilmaz B; Terekeci H; Sandal S; Kelestimur F
Rev Endocr Metab Disord; 2020 Mar; 21(1):127-147. PubMed ID: 31792807
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine and behavioral implications of endocrine disrupting chemicals in quail.
Ottinger MA; Abdelnabi MA; Henry P; McGary S; Thompson N; Wu JM
Horm Behav; 2001 Sep; 40(2):234-47. PubMed ID: 11534988
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism(s) of endocrine-disrupting chemicals and their potent oestrogenicity in diverse cells and tissues that express oestrogen receptors.
Lee HR; Jeung EB; Cho MH; Kim TH; Leung PC; Choi KC
J Cell Mol Med; 2013 Jan; 17(1):1-11. PubMed ID: 23279634
[TBL] [Abstract][Full Text] [Related]
17. Endocrine Disrupting Chemicals: Current Understanding, New Testing Strategies and Future Research Needs.
Street ME; Audouze K; Legler J; Sone H; Palanza P
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477789
[TBL] [Abstract][Full Text] [Related]
18. Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle.
Dickerson SM; Gore AC
Rev Endocr Metab Disord; 2007 Jun; 8(2):143-59. PubMed ID: 17674209
[TBL] [Abstract][Full Text] [Related]
19. Reproductive endocrine-disrupting effects of triclosan: Population exposure, present evidence and potential mechanisms.
Wang CF; Tian Y
Environ Pollut; 2015 Nov; 206():195-201. PubMed ID: 26184583
[TBL] [Abstract][Full Text] [Related]
20. Persistent environmental endocrine-disrupting chemicals in ovarian follicular fluid and
Björvang RD; Damdimopoulou P
Ups J Med Sci; 2020 May; 125(2):85-94. PubMed ID: 32093529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
